top of page
Executive Spotlights

Kyowa Kirin Appoints Steve Schaefer as President, North America to Manage Next Phase of Growth

Bedminster, NJ, April 11, 2023 (PRNewswire) -- Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd, a global specialty pharmaceutical company based in Japan, is announcing the appointment of Steve Schaefer as President, North America, effective today, April 11. Mr. Schaefer joins Kyowa Kirin North America (KKNA) after holding key leadership roles at top pharmaceutical companies, including Takeda Pharmaceuticals and Eli Lilly and Company.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page